Barrow, Hanley, Mewhinney & Strauss
PFE icon

Barrow, Hanley, Mewhinney & Strauss’s Pfizer PFE Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,211,763
Closed -$255M – 339
2019
Q2 		$255M Sell
6,211,763
-15,595,562
-72% -$619M 0.46% 57
2019
Q1 		$879M Sell
21,807,325
-10,991,358
-34% -$440M 1.58% 28
2018
Q4 		$1.36B Sell
32,798,683
-4,131,022
-11% -$171M 2.66% 2
2018
Q3 		$1.54B Sell
36,929,705
-4,430,989
-11% -$171M 2.45% 5
2018
Q2 		$1.42B Sell
41,360,694
-2,016,848
-5% -$68.9M 2.29% 6
2018
Q1 		$1.46B Sell
43,377,542
-1,113,936
-3% -$38.3M 2.32% 8
2017
Q4 		$1.53B Sell
44,491,478
-2,346,836
-5% -$80M 2.28% 7
2017
Q3 		$1.59B Sell
46,838,314
-1,926,504
-4% -$61.9M 2.39% 6
2017
Q2 		$1.55B Buy
48,764,818
+3,616,177
+8% +$114M 2.36% 10
2017
Q1 		$1.47B Sell
45,148,641
-2,705,004
-6% -$85.3M 2.21% 14
2016
Q4 		$1.47B Sell
47,853,645
-1,965,818
-4% -$60M 2.21% 12
2016
Q3 		$1.6B Sell
49,819,463
-1,806,713
-3% -$60.4M 2.44% 6
2016
Q2 		$1.72B Sell
51,626,176
-4,999,727
-9% -$160M 2.63% 7
2016
Q1 		$1.59B Sell
56,625,903
-145,695
-0.3% -$4.16M 2.43% 8
2015
Q4 		$1.74B Sell
56,771,598
-433,675
-0.8% -$13.6M 2.59% 6
2015
Q3 		$1.7B Sell
57,205,273
-1,138,744
-2% -$36.5M 2.62% 6
2015
Q2 		$1.86B Buy
58,344,017
+289,463
+0.5% +$9.43M 2.53% 5
2015
Q1 		$1.92B Sell
58,054,554
-8,094,658
-12% -$257M 2.6% 5
2014
Q4 		$1.95B Buy
66,149,212
+621,103
+0.9% +$17.8M 2.62% 5
2014
Q3 		$1.84B Buy
65,528,109
+1,761,048
+3% +$49.4M 2.51% 6
2014
Q2 		$1.8B Buy
63,767,061
+637,129
+1% +$18.2M 2.41% 8
2014
Q1 		$1.92B Sell
63,129,932
-1,650,264
-3% -$49.2M 2.75% 4
2013
Q4 		$1.88B Buy
64,780,196
+594,056
+0.9% +$17.3M 2.73% 6
2013
Q3 		$1.75B Buy
64,186,140
+70,304
+0.1% +$1.91M 2.8% 3
2013
Q2 		$1.7B Buy
+64,115,836
New +$1.77B 2.86% 3

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's PFE Position: Q3 2019 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Pfizer (PFE) in Q3 2019, closing a stake of 6,211,763 shares — an estimated $255M sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $1.95B in Q4 2014. 2,322 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 6,211,763 Pfizer shares in Q3 2019, an estimated $255M.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Pfizer position peaked at $1.95B in Q4 2014.
  • 2,322 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q3 2019, filed 14 Nov 2019.